[Methoxybutropate in the therapy of PID (pelvic inflammatory diseases)].
A study has been carried out on patients suffering from pelvic inflammatory disease (PID) in chronic form, so as to evaluate the effectiveness of treatment with methoxybutropate (Benflogin-Angelini). The study was carried out on 20 outpatients treated for eight weeks with 300 mg of methoxybutropate three times a day. The results have highlighted the noteworthy effectiveness and high tolerance of methoxybutropate in the treatment of PID.
Stillo
A
A
Cattedra di Patologia, Ostetrica e Ginecologica, Università degli Studi, Milano.
Rossi
A
A
Lorenzin
M G
MG
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006139:Guaiacol / Q000031:analogs & derivatives; D006801:Humans; D007052:Ibuprofen / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; C020176:metoxibutropate; D006139:Guaiacol; D007052:Ibuprofen
Il metossibutropato nella terapia delle PID.